1. Home
  2. RPHM vs BWEN Comparison

RPHM vs BWEN Comparison

Compare RPHM & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPHM
  • BWEN
  • Stock Information
  • Founded
  • RPHM 2014
  • BWEN N/A
  • Country
  • RPHM United States
  • BWEN United States
  • Employees
  • RPHM N/A
  • BWEN N/A
  • Industry
  • RPHM Biotechnology: Pharmaceutical Preparations
  • BWEN Industrial Machinery/Components
  • Sector
  • RPHM Health Care
  • BWEN Industrials
  • Exchange
  • RPHM Nasdaq
  • BWEN Nasdaq
  • Market Cap
  • RPHM 47.5M
  • BWEN 46.4M
  • IPO Year
  • RPHM 2021
  • BWEN N/A
  • Fundamental
  • Price
  • RPHM $18.20
  • BWEN $2.19
  • Analyst Decision
  • RPHM Hold
  • BWEN Strong Buy
  • Analyst Count
  • RPHM 6
  • BWEN 3
  • Target Price
  • RPHM $2.26
  • BWEN $5.17
  • AVG Volume (30 Days)
  • RPHM 345.4K
  • BWEN 100.5K
  • Earning Date
  • RPHM 11-11-2024
  • BWEN 11-06-2024
  • Dividend Yield
  • RPHM N/A
  • BWEN N/A
  • EPS Growth
  • RPHM N/A
  • BWEN N/A
  • EPS
  • RPHM N/A
  • BWEN 0.35
  • Revenue
  • RPHM N/A
  • BWEN $177,829,000.00
  • Revenue This Year
  • RPHM N/A
  • BWEN N/A
  • Revenue Next Year
  • RPHM N/A
  • BWEN $24.98
  • P/E Ratio
  • RPHM N/A
  • BWEN $6.44
  • Revenue Growth
  • RPHM N/A
  • BWEN N/A
  • 52 Week Low
  • RPHM $1.68
  • BWEN $2.01
  • 52 Week High
  • RPHM $92.10
  • BWEN $4.65
  • Technical
  • Relative Strength Index (RSI)
  • RPHM 18.64
  • BWEN 51.07
  • Support Level
  • RPHM $16.10
  • BWEN $2.11
  • Resistance Level
  • RPHM $19.00
  • BWEN $2.35
  • Average True Range (ATR)
  • RPHM 1.09
  • BWEN 0.10
  • MACD
  • RPHM -1.48
  • BWEN 0.01
  • Stochastic Oscillator
  • RPHM 0.00
  • BWEN 57.14

About RPHM Reneo Pharmaceuticals Inc.

Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through three operating segments namely Heavy Fabrications, Gearing and Industrial Solutions.

Share on Social Networks: